New Key Statistics Module, Z-Score and F-Score
NAS:RIGL Key Ratios
Market Cap $ M | 192.94 |
Enterprise Value $ M | 196.59 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.64 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 116.00 |
EPS (TTM) $ | -0.14 |
Beneish M-Score | -3.46 |
10-y EBITDA Growth Rate % | 21.00 |
5-y EBITDA Growth Rate % | 22.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.79 |
EV-to-EBITDA | -11.58 |
PEG | -- |
Shares Outstanding M | 175.40 |
Net Margin (%) | -21.47 |
Operating Margin % | -17.53 |
Pre-tax Margin (%) | -21.47 |
Quick Ratio | 1.76 |
Current Ratio | 1.86 |
ROA % (ttm) | -20.65 |
ROE % (ttm) | -- |
ROIC % (ttm) | -42.22 |
Dividend Yield % | -- |
Altman Z-Score | -15.06 |
RIGL Number of Guru Trades
RIGL Volume of Guru Trades
Gurus Latest Trades with NAS:RIGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RIGL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rigel Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RIGL
Total 0- 1